Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc.

Discover top medications for 'treating Parkinsons Disease'? This page compiles essential information on generic and brand-name drugs specifically used for Parkinsons Disease treatment.Here ...

Scientists have made a potentially “life-changing” discovery that could pave the way for new drugs to treat Parkinson’s disease. Experts have known for several decades that the PINK1 protein ...

They treated flies with the drug IU1 ... advances in anti-aging therapy. "Reduced protein homeostasis is a major characteristic of degenerative diseases such as Alzheimer's and Parkinson's disease.

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Denmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the clinic – a human antibody that the company hopes will tackle the underlying cause of the condition.

Pioneering Cancer TreatmentAnti-tumor Active Pharmaceutical Ingredients (APIs) are vital in today's medical landscape, addressing one of the most pressing health challenges: cancer. These APIs form ...